Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1879 1
1882 1
1898 1
1911 1
1929 1
1931 2
1933 1
1934 1
1943 1
1945 6
1946 25
1947 37
1948 59
1949 58
1950 125
1951 129
1952 102
1953 107
1954 100
1955 93
1956 101
1957 122
1958 107
1959 115
1960 107
1961 128
1962 131
1963 204
1964 223
1965 262
1966 238
1967 213
1968 249
1969 272
1970 295
1971 264
1972 321
1973 354
1974 373
1975 382
1976 417
1977 469
1978 510
1979 474
1980 520
1981 517
1982 589
1983 609
1984 672
1985 621
1986 669
1987 768
1988 718
1989 782
1990 723
1991 764
1992 786
1993 805
1994 961
1995 1008
1996 1079
1997 1178
1998 1317
1999 1512
2000 1648
2001 1661
2002 1667
2003 1840
2004 2017
2005 2263
2006 2407
2007 2652
2008 2907
2009 3088
2010 3481
2011 3937
2012 4265
2013 4788
2014 5109
2015 5294
2016 5474
2017 5543
2018 5692
2019 6088
2020 6958
2021 7420
2022 7256
2023 6514
2024 6826
2025 7203
2026 4894

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128,220 results

Results by year

Filters applied: . Clear all
Page 1
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Correale J, et al. Brain. 2017 Mar 1;140(3):527-546. doi: 10.1093/brain/aww258. Brain. 2017. PMID: 27794524 Free article. Review.
In contrast, current therapeutic options for progressive multiple sclerosis remain comparatively disappointing and challenging. One possible explanation is a lack of understanding of pathogenic mechanisms driving progressive multiple sclerosis. ...Alth …
In contrast, current therapeutic options for progressive multiple sclerosis remain comparatively disappointing and challenging …
Multiple sclerosis.
Wei FC. Wei FC. Biomed J. 2014 Mar-Apr;37(2):33. doi: 10.4103/2319-4170.130317. Biomed J. 2014. PMID: 24732656 Free article. No abstract available.
Multiple sclerosis under the spotlight.
The Lancet Neurology. The Lancet Neurology. Lancet Neurol. 2021 Jul;20(7):497. doi: 10.1016/S1474-4422(21)00170-8. Lancet Neurol. 2021. PMID: 34146496 No abstract available.
Pediatric Multiple Sclerosis: A Review.
Langille MM, Rutatangwa A, Francisco C. Langille MM, et al. Adv Pediatr. 2019 Aug;66:209-229. doi: 10.1016/j.yapd.2019.03.003. Epub 2019 Apr 20. Adv Pediatr. 2019. PMID: 31230695 Review. No abstract available.
Multiple sclerosis.
Nicholas R, Rashid W. Nicholas R, et al. Am Fam Physician. 2013 May 15;87(10):712-4. Am Fam Physician. 2013. PMID: 23939450 Free article. Review. No abstract available.
Multiple sclerosis.
Owens B. Owens B. Nature. 2016 Nov 30;540(7631):S1. doi: 10.1038/540S1a. Nature. 2016. PMID: 27902684 No abstract available.
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA.
Carlson AK, Fox RJ. Carlson AK, et al. Neurol Clin. 2024 Feb;42(1):39-54. doi: 10.1016/j.ncl.2023.07.002. Epub 2023 Aug 21. Neurol Clin. 2024. PMID: 37980122 Review.
More than one million individuals are impacted by progressive forms of multiple sclerosis. The literature examining the management of MS has focused primarily on relapsing forms of disease, and effective therapies targeting progressive mechanisms in MS remains a sig …
More than one million individuals are impacted by progressive forms of multiple sclerosis. The literature examining the manage …
Multiple sclerosis.
Brody H. Brody H. Nature. 2012 Apr 12;484(7393):S1. doi: 10.1038/nature11104. Nature. 2012. PMID: 22509502 No abstract available.
Multiple Sclerosis: Basic and Clinical.
Buzzard K, Chan WH, Kilpatrick T, Murray S. Buzzard K, et al. Adv Neurobiol. 2017;15:211-252. doi: 10.1007/978-3-319-57193-5_8. Adv Neurobiol. 2017. PMID: 28674983 Review.
Multiple sclerosis (MS) is the most common neurodegenerative disease affecting young adults in our community. ...
Multiple sclerosis (MS) is the most common neurodegenerative disease affecting young adults in our community. ...
Multiple Sclerosis: Eyes on the Future.
Costello FE, Burton JM. Costello FE, et al. J Neuroophthalmol. 2018 Mar;38(1):81-84. doi: 10.1097/WNO.0000000000000631. J Neuroophthalmol. 2018. PMID: 29438264 Review. No abstract available.
128,220 results
You have reached the last available page of results. Please see the User Guide for more information.